The IVD industry translates lab results into faster clinical decisions, from routine testing to responses for infectious disease outbreaks and chronic care. Across the page, you’ll explore where growth is concentrated—especially in North America—and how regional dynamics differ in Europe and Asia Pacific. We also break down which segments, from reagents to molecular and clinical chemistry, are driving adoption and competitive positioning, including how emerging technologies are changing workflows.
Key Takeaways
- The global in vitro diagnostics (IVD) market was valued at USD 85.2 billion in 2022 and is projected to grow at a CAGR of 5.2% from 2023 to 2030, reaching USD 128.9 billion by 2030
- North America dominated the IVD market with a share of 39.6% in 2022, driven by advanced healthcare infrastructure and high adoption of innovative diagnostics
- The reagents and kits segment accounted for 72.4% of the IVD market revenue in 2022, due to high consumption in routine testing
- Roche Diagnostics held 15.2% global IVD market share in 2022 with revenue USD 17.5 billion
- Abbott Laboratories IVD revenue USD 11.2 billion in 2022, 13.1% market share
- Siemens Healthineers diagnostics division revenue USD 20.1 billion in 2022, 18.4% share
- North America clinical chemistry market valued at USD 10.2 billion in 2022, 40% global share
- U.S. IVD market size USD 30.1 billion in 2022, largest in North America
- Europe IVD market at USD 24.5 billion in 2022, with Germany leading at 22% regional share
- Clinical chemistry analyzers segment valued at USD 12.9 billion in 2022
- Immunoassays reagents market size was USD 28.4 billion in 2022, growing at 6.5% CAGR
- Molecular diagnostics market reached USD 15.3 billion in 2022, with PCR dominating at 42%
- CRISPR-based diagnostics innovations funded USD 500 million in 2022 by key players
- AI integration in IVD analyzers expected to reduce turnaround time by 30% by 2025
- Liquid biopsy tests in IVD grew 18.5% in 2022, market USD 4.3 billion
In 2022 the IVD market reached $85.2 billion, led by North America, and is set to grow steadily through 2030.
Related reading
01 · Category
Global Market Overview30 stats
01
The global in vitro diagnostics (IVD) market was valued at USD 85.2 billion in 2022 and is projected to grow at a CAGR of 5.2% from 2023 to 2030, reaching USD 128.9 billion by 2030
02
North America dominated the IVD market with a share of 39.6% in 2022, driven by advanced healthcare infrastructure and high adoption of innovative diagnostics
03
The reagents and kits segment accounted for 72.4% of the IVD market revenue in 2022, due to high consumption in routine testing
04
Infectious diseases held the largest application segment share of 28.3% in the IVD market in 2022, fueled by rising incidences of COVID-19 and other epidemics
05
Fully automated instruments represented 45.7% of the IVD instruments market in 2022, owing to efficiency and reduced human error
06
The IVD market in Asia Pacific is expected to grow at the fastest CAGR of 6.8% from 2023 to 2030, driven by expanding healthcare access in India and China
07
Point-of-care (POC) testing segment is anticipated to register a CAGR of 7.1% in the IVD market from 2023 to 2030, due to demand for rapid diagnostics
08
The molecular diagnostics sub-segment within IVD grew at a CAGR of 8.4% from 2017 to 2022, propelled by PCR and NGS technologies
09
Global IVD market size reached USD 77.2 billion in 2020, impacted by COVID-19 surge in testing demand
10
Immunoassay technology held 52.3% share in IVD market in 2022, due to versatility in detecting proteins and hormones
11
The IVD market is projected to reach USD 145.5 billion by 2028 at a CAGR of 5.6%, supported by chronic disease prevalence
12
Clinical chemistry segment dominated with 51.2% revenue share in 2022, used for electrolyte and metabolite analysis
13
IVD market in Europe accounted for 28.5% share in 2022, bolstered by regulatory frameworks like IVDR
14
Tissue diagnostics segment expected to grow at CAGR 7.2% through 2030, driven by oncology applications
15
Global IVD market CAGR projected at 4.9% from 2023-2028, with consumables leading at 6.1% CAGR
16
The hematology segment in IVD market was valued at USD 12.4 billion in 2022
17
IVD market expected to hit USD 132.8 billion by 2031 at CAGR 5.8%, per Allied Market Research
18
Diabetes segment in IVD grew to USD 18.7 billion in 2022 due to rising global prevalence
19
IVD market CAGR of 7.5% forecasted for 2023-2030 in emerging markets
20
Microbiology IVD sub-market valued at USD 15.6 billion in 2022
21
IVD market to reach USD 150 billion by 2030 at 6.2% CAGR, per Persistence
22
Over 1.2 billion IVD tests performed annually worldwide in 2022
23
IVD industry R&D investment exceeded USD 10 billion in 2022 globally
24
Digital IVD solutions expected to grow at 12.3% CAGR to 2030
25
Global IVD consumables market at USD 60.5 billion in 2023
26
IVD market share of POC diagnostics rose to 22.1% in 2022
27
Self-testing IVD kits market valued at USD 5.8 billion in 2022
28
IVD market impacted by 15% growth in 2020 due to pandemic testing
29
Projected IVD market volume of 15 billion tests by 2025
30
IVD software market to grow at 9.8% CAGR to USD 4.2 billion by 2027
Interpretation
Global Market Overview Interpretation
In the global market overview of IVD, the industry reached USD 85.2 billion in 2022 and is set to expand at a 5.2% CAGR, with Asia Pacific projected for the fastest growth at 6.8% through 2030.
02 · Category
Key Players And Revenues25 stats
01
Roche Diagnostics held 15.2% global IVD market share in 2022 with revenue USD 17.5 billion
02
Abbott Laboratories IVD revenue USD 11.2 billion in 2022, 13.1% market share
03
Siemens Healthineers diagnostics division revenue USD 20.1 billion in 2022, 18.4% share
04
Danaher Corporation (Beckman Coulter) IVD sales USD 6.8 billion in 2022
05
Thermo Fisher Scientific life sciences revenue including IVD USD 13.7 billion in 2022
06
Becton Dickinson (BD) diagnostics revenue USD 4.9 billion in 2022
07
Bio-Rad Laboratories IVD revenue USD 1.6 billion in 2022
08
Ortho Clinical Diagnostics (QuidelOrtho) revenue USD 2.3 billion in 2022 post-merger
09
bioMérieux IVD sales EUR 3.5 billion (USD 3.8 billion) in 2022
10
Hologic diagnostics revenue USD 1.2 billion in 2022
11
Sysmex Corporation IVD revenue JPY 410 billion (USD 3.1 billion) in 2022
12
Qiagen NV revenue USD 1.8 billion in 2022, molecular IVD focus
13
Illumina NGS revenue USD 4.6 billion in 2022, key in IVD
14
PerkinElmer (Revvity) diagnostics USD 2.9 billion in 2022
15
Fujirebio (H.U. Group) IVD revenue JPY 50 billion in 2022
16
Arkray Inc. revenue USD 0.8 billion in 2022, diabetes focus
17
Mindray Medical IVD revenue CNY 4.2 billion (USD 0.6 billion) in 2022
18
Snibe Diagnostic revenue CNY 2.5 billion in 2022, emerging player
19
Roche's cobas platform generated 40% of its diagnostics revenue in 2022
20
Abbott's Alinity systems sales USD 2.4 billion in 2022
21
Siemens Atellica analyzers contributed USD 3.2 billion in 2022
22
Beckman Coulter DxH hematology series over 10,000 units sold globally in 2022
23
BD FACSAria flow cytometers revenue USD 0.7 billion in 2022
24
bioMérieux VIDAS immunoassay sales EUR 1.1 billion in 2022
25
Point-of-care glucose testing by Roche Accu-Chek USD 1.5 billion in 2022
Interpretation
Key Players And Revenues Interpretation
In the key players and revenues segment of the IVD market, just three companies dominate with Roche at 17.5 billion revenue and 15.2% share in 2022, Siemens Healthineers at 20.1 billion and 18.4% share, and Abbott at 11.2 billion and 13.1% share, highlighting how revenue scale strongly tracks market leadership.
03 · Category
Regional Insights21 stats
01
North America clinical chemistry market valued at USD 10.2 billion in 2022, 40% global share
02
U.S. IVD market size USD 30.1 billion in 2022, largest in North America
03
Europe IVD market at USD 24.5 billion in 2022, with Germany leading at 22% regional share
04
Asia Pacific IVD market grew 7.3% CAGR 2018-2022, valued at USD 22.8 billion
05
China IVD market reached USD 12.4 billion in 2022, CAGR 9.1% forecasted to 2030
06
India IVD market size USD 1.8 billion in 2022, expected CAGR 12.5% due to healthcare expansion
07
Japan IVD market valued at USD 5.6 billion in 2022, driven by aging population
08
Latin America IVD market USD 4.2 billion in 2022, Brazil at 45% share
09
Middle East & Africa IVD growth at 6.8% CAGR to 2030, market size USD 3.9 billion in 2022
10
U.S. POC IVD market USD 7.8 billion in 2022
11
Germany molecular diagnostics market USD 2.1 billion in 2022
12
South Korea IVD market USD 2.3 billion in 2022, high adoption of robotics
13
Brazil IVD imports valued at USD 1.2 billion in 2022
14
Australia IVD market USD 1.1 billion in 2022, CAGR 5.4%
15
UK IVD market share 15% of Europe in 2022, USD 3.7 billion
16
Saudi Arabia IVD market growing at 8.2% CAGR, USD 0.9 billion in 2022
17
Canada IVD expenditure USD 4.5 billion in 2022
18
Mexico clinical diagnostics market USD 1.4 billion in 2022
19
France IVD market USD 4.8 billion in 2022, immunoassays leading
20
Indonesia IVD market USD 0.7 billion in 2022, rapid growth projected
21
South Africa IVD market USD 0.5 billion in 2022, infectious diseases focus
Interpretation
Regional Insights Interpretation
Regional demand for IVDs is showing uneven but strong momentum, with North America leading clinical chemistry at USD 10.2 billion in 2022 and Asia Pacific expanding fastest at a 7.3% CAGR from 2018 to 2022 as its market reaches USD 22.8 billion.
More related reading
04 · Category
Segment Wise Analysis23 stats
01
Clinical chemistry analyzers segment valued at USD 12.9 billion in 2022
02
Immunoassays reagents market size was USD 28.4 billion in 2022, growing at 6.5% CAGR
03
Molecular diagnostics market reached USD 15.3 billion in 2022, with PCR dominating at 42%
04
Hematology testing segment accounted for 18.5% of IVD market in 2022, valued at USD 14.2 billion
05
Microbiology IVD market size USD 17.8 billion in 2022, CAGR 5.9% to 2030
06
Coagulation testing in IVD valued at USD 4.1 billion in 2022, driven by cardiovascular diseases
07
Tissue diagnostics market was USD 5.6 billion in 2022, with immunohistochemistry at 55% share
08
Blood glucose monitoring devices segment in IVD at USD 12.7 billion in 2022
09
ELISA kits market size USD 3.2 billion in 2022, used in 70% of immunoassay tests
10
Next-generation sequencing (NGS) in IVD valued at USD 4.8 billion in 2022, CAGR 21.7%
11
Urinalysis market within IVD reached USD 1.5 billion in 2022
12
Cardiac biomarkers testing market USD 5.9 billion in 2022
13
HLA typing for transplants in IVD at USD 0.6 billion in 2022
14
Consumables in clinical chemistry IVD accounted for 68% share in 2022
15
POC blood gas testing market USD 2.3 billion in 2022
16
Flow cytometry in IVD valued at USD 4.5 billion in 2022, CAGR 9.2%
17
Infectious disease reagents segment held 35.2% in molecular IVD in 2022
18
Oncology IVD tests market USD 8.7 billion in 2022
19
Lipid profile testing in clinical chemistry at 25% segment share in 2022
20
Rapid diagnostic tests (RDTs) market USD 28.9 billion in 2022 for infectious diseases
21
Autoimmune disease diagnostics USD 5.2 billion in 2022
22
HbA1c testing kits market USD 1.9 billion in 2022
23
Microbiology culture media segment USD 3.4 billion in 2022
Interpretation
Segment Wise Analysis Interpretation
Within the segment-wise analysis of the IVD industry, immunoassay reagents led with USD 28.4 billion in 2022 and a 6.5% CAGR while molecular diagnostics reached USD 15.3 billion with PCR accounting for 42%, underscoring sustained high growth at the core testing segments.
05 · Category
Trends And Innovations19 stats
01
CRISPR-based diagnostics innovations funded USD 500 million in 2022 by key players
02
AI integration in IVD analyzers expected to reduce turnaround time by 30% by 2025
03
Liquid biopsy tests in IVD grew 18.5% in 2022, market USD 4.3 billion
04
Digital pathology market within IVD USD 0.9 billion in 2022, CAGR 13.2%
05
Microfluidics technology in IVD valued at USD 3.7 billion in 2022
06
Companion diagnostics market USD 7.5 billion in 2022, tied to personalized medicine
07
Biosensors in POC IVD market USD 8.2 billion in 2022, CAGR 9.8%
08
Nanotechnology applications in IVD expected to grow at 12.4% CAGR to 2030
09
Wearable diagnostics integrated with IVD data projected USD 45 billion by 2028
10
Multiplex assays in IVD market USD 2.8 billion in 2022, enabling simultaneous testing
11
Lab-on-a-chip devices sales USD 0.4 billion in 2022, CAGR 16.7%
12
Telepathology systems adoption rose 25% in 2022 post-pandemic
13
Single-cell analysis in IVD USD 3.1 billion in 2022
14
Organ-on-a-chip technology R&D investment USD 200 million in 2022
15
Blockchain for IVD data security implemented in 15% of labs by 2022
16
5G-enabled remote diagnostics trialed in 20 countries in 2022
17
Paper-based diagnostics for low-resource settings USD 0.3 billion in 2022
18
Mass spectrometry in IVD grew to USD 5.4 billion in 2022
19
Quantum dots in IVD imaging applications emerging, market USD 0.1 billion in 2022
Interpretation
Trends And Innovations Interpretation
In the Trends and Innovations landscape, rapid technology shifts are clearly accelerating, with CRISPR-based diagnostics funding reaching USD 500 million in 2022 and liquid biopsy tests climbing 18.5% to USD 4.3 billion while AI in IVD analyzers is expected to cut turnaround time by 30% by 2025.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Rachel Svensson. (2026, February 13). Ivd Industry Statistics. Gitnux. https://gitnux.org/ivd-industry-statistics
MLA
Rachel Svensson. "Ivd Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/ivd-industry-statistics.
Chicago
Rachel Svensson. 2026. "Ivd Industry Statistics." Gitnux. https://gitnux.org/ivd-industry-statistics.
Sources & references
43 datasets cited across this report · attribution is report-level